Neuroimaging of Parkinson's

Summary

Parkinson's Disease (PD) is a neurodegenerative disorder caused by dysfunction in both subcortical structures and the cortex. The investigators recently discovered a new brain system called the Somato-Cognitive Action Network (SCAN), which could be a primary locus of dysfunction in PD. Here, the investigators will use magnetic resonance imaging techniques in PD patients to test whether SCAN is critical for PD. The investigators will determine whether SCAN is connected to PD-relevant subcortical structures, and whether PD patients exhibit altered subcortical-to-SCAN connectivity.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Parkinsons Disease (PD)

Eligibility basics and study details

Study type

Observational

Phase

Not applicable

Ages

40 years and older

Sex

All

Healthy volunteers

Accepted

Sponsor

Washington University School of Medicine

Last updated on ClinicalTrials.gov

April 13, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites